Idiopathic pulmonary hemosiderosis (IPH) is a rare disorder in children characterized by recurrent episodes of diffuse alveolar hemorrhage, presenting with hemoptysis, iron deficiency anemia, and pulmonary infiltrates. Mortality rates can be high, but survival rates have improved, with a historical average survival of 2.5 years post-diagnosis now showing 86% of patients surviving beyond 5 years. A study on children with IPH found that the median age of onset was 5 years, with cough, hemoptysis, fever, and dyspnea as main initial symptoms. Anemia and iron deficiency were common, and chest imaging revealed abnormalities. Treatment involves corticosteroids, with some patients achieving remission while others face complications leading to death. Bronchoalveolar lavage fluid analysis is a confirmatory method for diagnosing pulmonary hemorrhage, and early recognition and appropriate treatment are crucial for improving survival and prognosis in IPH patients. Further research is needed on environmental factors contributing to IPH and the challenges of diagnosing this condition in children with unexplained anemia and lung abnormalities.